Schizophrenia  >>  lurasidone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lurasidone / Generic mfg.
NCT00044044: A Comparison of Study Drug With Placebo and Haloperidol in Patients With Schizophrenia

Checkmark ACNP 2015
Dec 2015 - Dec 2015: ACNP 2015
Completed
2
356
US
Lurasidone 20 mg, Lurasidone 40mg, Lurasidone 80 mg, Haloperidol 10mg, Placebo
Sunovion
Schizophrenia
05/03
05/03
NCT00044005: Safety and Tolerability Study of Drug to Treat Schizophrenia

Completed
2
98
US
Lurasidone 20 mg, Lurasidone 40 mg, Lurasidone 80mg
Sunovion
Schizophrenia
11/03
11/03
NCT00088634: A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of Schizophrenia

Checkmark ACNP 2015
Dec 2015 - Dec 2015: ACNP 2015
Completed
2
180
US
Lurasidone, Placebo
Sunovion
Schizophrenia
12/04
12/04
NCT00088621: A Study to Test the Safety and Tolerability of a New Medication in the Treatment of Schizophrenia

Completed
2
61
US
Lurasidone 80mg tablet, Lurasidone
Sunovion
Schizophrenia
10/05
10/05
NCT01731119: Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Completed
2
9
US
Latuda©, Lurasidone Hydrochloride tablets
University of North Carolina, Chapel Hill, Foundation of Hope, North Carolina
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOS, Autistic Disorder, Asperger Syndrome, Child Development Disorders, Pervasive, Bipolar I Disorder, Bipolar II Disorder, Mood Disorder NOS, Severe Major Depression With Psychotic Features, Single Episode Major Depression Without Psychotic Symptoms, Severe Mood Disorder With Psychotic Features
08/14
08/14

Download Options